Eqitx to raise $1.8 million

By Melissa Trudinger
Tuesday, 07 December, 2004

Melbourne-based biotech managed investment group EQiTX (ASX: EQX) will ask shareholders to approve a AUD$1.8 million capital raising to provide working capital for its two projects ZingoTX and VacTX.

The placement, involving the issue of six million new shares at $0.30 plus two million free attaching options with an exercise price of $0.20, is to be underwritten by Cunningham Securities.

Sleep apnoea patients who use CPAP live longer: study

CPAP therapy has been found to significantly reduce the risk of death for people with obstructive...

Does exercise really extend lifespan? It's complicated

Physical activity is seen as a way to extend the human lifespan, but the benefits of physical...

Nature helps to relieve physical pain

Experiencing nature, even in the form of watching nature videos, can alleviate acute physical pain.

Content from other channels on our network

APHA calls "bulldust" on claims insurers cannot pay in full

Healthscope proposes Northern Beaches Hospital 'hand-back'

IVF incident: "All of us at Monash IVF are devastated"

All metropolitan public hospitals miss out on green light

Psychologist training pathway review launched

GLP-1 weight loss drugs' effect on food and drink choices

Heat and Control announces acquisition of Tek-Dry Systems and Hunt Heat Exchangers

Meat industry handling and freezing solutions on show at IFFA

Making the mark for egg producers

$25K FaBA grant to advance antibiotic detection in food

Reducing upfront carbon in built environment: report

The 3 key risks directors need to manage amid climate reporting uncertainty

Green chemistry turns waste CO2 into amino acids

Circularity needed at scale for Aust building industry

Textile recycler BlockTexx wins Gold for sustainability